CSIMarket
 
Phibro Animal Health Corporation  (PAHC)
Other Ticker:  
 
 
Price: $23.4900 $0.60 2.621%
Day's High: $24.02 Week Perf: 12.45 %
Day's Low: $ 22.96 30 Day Perf: 10.75 %
Volume (M): 217 52 Wk High: $ 24.02
Volume (M$): $ 5,088 52 Wk Avg: $15.07
Open: $22.97 52 Wk Low: $9.40



 Market Capitalization (Millions $) 946
 Shares Outstanding (Millions) 40
 Employees 1,940
 Revenues (TTM) (Millions $) 1,017
 Net Income (TTM) (Millions $) 2
 Cash Flow (TTM) (Millions $) 29
 Capital Exp. (TTM) (Millions $) 41

Phibro Animal Health Corporation
Phibro Animal Health Corporation is a world renowned animal health and nutrition company that focuses on the development, manufacturing and marketing of a wide range of innovative animal health products for livestock, poultry, aquaculture and pet industries worldwide.

The company was founded in 1946 and has been steadily expanding its operations to reach a global network of customers and partners through its subsidiaries in the Americas, Europe, the Middle East, and Asia.

Phibro Animal Health is organized into three main business segments: Animal Health, Nutrition, and Performance Products. Under the Animal Health segment, the company provides veterinary products and solutions such as antibiotics, vaccines, and parasiticides that help improve animal health and productivity.

The company's Nutrition segment offers various premixes, concentrates, and feed additives designed to enhance the nutritional value of animal feed and improve the performance of livestock and aquaculture.

Under the Performance Products segment, Phibro Animal Health provides non-antibiotic growth promoters, mold inhibitors, and other additives that help enhance animal health and growth without contributing to antibiotic resistance.

Phibro Animal Health boasts a vast portfolio of more than 2,500 products that cater to a vast array of animal species, including cattle, swine, poultry, fish, pets, among others. The company's focus on research and development has resulted in many groundbreaking products that have revolutionized the animal health and nutrition industry.

Phibro Animal Health Corporation operates under a core set of values that prioritize animal health, customer satisfaction, and employee well-being. The company is committed to sustainability and ethical business practices that ensure the long-term well-being of the environment and communities where it operates.

Overall, Phibro Animal Health Corporation is a reliable and innovative company that provides top-quality animal health and nutrition products and solutions that help farmers, ranchers, and businesses maximize animal health and productivity while optimizing profitability.


   Company Address: Glenpointe Centre East, 3rd Floor Teaneck 7666 NJ
   Company Phone Number: 329-7300   Stock Exchange / Ticker: NASDAQ PAHC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Dividend

Phibro Animal Health Corporation Declares Increased Dividend Amid Strong Stock Performance, Signaling Confidence and Growth

Published Wed, Jul 31 2024 5:06 AM UTC


---

TEANECK, N.J. ?? In a recent announcement that resonates positively with investors, the Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) declared a quarterly cash dividend of $0.12 per share on both its Class A and Class B common stock. This decision, effective September 25, 2024, for shareholders on record as of the close of business o...

Business Update

Phibro Animal Health Corporation Continues to Advance Animal Health, Nutrition, and Sustainability with Annual ESG Re...

Published Thu, Jun 6 2024 12:38 AM UTC

In a recent press release, Phibro Animal Health Corporation proudly announced the release of its third annual Environmental, Social, and Governance (ESG) Report, showcasing the company's accomplishments in 2023. Recognizing the interconnectedness between people, animals, and the planet, Phibro strives to optimize animal health and nutrition for a better future and a sustaina...

Business Update

Connecting Lives for a Sustainable Future: Phibro Animal Health Corporations Journey towards ESG Excellence ...

Published Wed, Jun 5 2024 8:38 PM UTC

Phibro Animal Health Corporation's Third Annual ESG Report Highlights Commitment to Animal Health, Nutrition, and SustainabilityPhibro Animal Health Corporation, a leading provider of animal health and nutrition solutions, is proud to release its third annual Environmental, Social, and Governance (ESG) Report, showcasing their accomplishments in 2023. The report demonstrate...

Phibro Animal Health Corporation

Phibro Animal Health Corporation Reports Strong Revenue Growth in Latest Fiscal Period

As an analyst for the CSIMarket.com, I have been closely following the financial performance of Phibro Animal Health Corporation. The latest fiscal period has presented contradictory numbers, with revenue rising by 6.89% to $262.60 million compared to the previous year's $245.67 million. However, income fell by -16% to $0.21 per share from $0.25 in the prior reporting period. Despite this disparity, Phibro Animal Health Corporation's top-line growth in the third quarter of 2024 has outperformed its peers in the Major Pharmaceutical Preparations sector.
While the average revenue growth for Major Pharmaceutical Preparations companies during the same period was 2.72%, Phibro Animal Health Corporation's revenue surged by 5.202% from $249.62 million. In addition, its earnings per share saw a significant improvement, increasing by 600% from $0.03 per share. These results indicate that the company has been able to capitalize on market opportunities and provide value to its customers and local communities.

Business Update

Zoetis, headquartered in Parsippany, New Jersey, is known for its wide range of innovative animal health solutions. Their MFA product portfolio includes additives that are mixed with animal feed to enhance nutrition, prevent diseases, and promote growth. However, as part of their ongoing business strategy, Zoetis has decided to divest this particular segment and focus on their core areas of expe...

Published Mon, Apr 29 2024 4:08 AM UTC

Zoetis, a leading animal health company, recently announced its decision to sell its medicated feed additive (MFA) product portfolio to Phibro Animal Health Corporation in a definitive agreement worth $350 million. The acquisition includes certain water-soluble products and related assets and is expected to be completed in the second half of the calendar year 2024. This stra...







Phibro Animal Health's Segments
Animal Health    68.89 % of total Revenue
Mineral Nutrition    24.4 % of total Revenue
Performance Products    6.71 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com